- Home
- RNXT vs EKSO Comparison
RNXT vs EKSO Comparison
Compare RNXT & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNXT | EKSO |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 37.9M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RNXT | EKSO |
|---|---|---|
| Price | $0.86 | $10.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.25 | ★ $9.50 |
| AVG Volume (30 Days) | ★ 305.0K | 59.2K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 41.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $194.66 | $81.23 |
| Revenue Next Year | $279.78 | $7.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $0.23 |
| 52 Week High | $1.45 | $13.50 |
Technical Indicators
Market Signals| Indicator | RNXT | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | 56.33 |
| Support Level | $0.82 | $8.30 |
| Resistance Level | $1.07 | $11.18 |
| Average True Range (ATR) | 0.06 | 0.88 |
| MACD | -0.02 | 0.16 |
| Stochastic Oscillator | 9.83 | 76.93 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.